- Home
- FSBC vs ARCT Comparison
FSBC vs ARCT Comparison
Compare FSBC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- ARCT
- Stock Information
- Founded
- FSBC 2002
- ARCT 2013
- Country
- FSBC United States
- ARCT United States
- Employees
- FSBC N/A
- ARCT N/A
- Industry
- FSBC Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- FSBC Finance
- ARCT Health Care
- Exchange
- FSBC Nasdaq
- ARCT Nasdaq
- Market Cap
- FSBC 565.6M
- ARCT 298.3M
- IPO Year
- FSBC 2021
- ARCT N/A
- Fundamental
- Price
- FSBC $30.03
- ARCT $13.27
- Analyst Decision
- FSBC Buy
- ARCT Strong Buy
- Analyst Count
- FSBC 4
- ARCT 8
- Target Price
- FSBC $34.75
- ARCT $52.83
- AVG Volume (30 Days)
- FSBC 56.1K
- ARCT 474.4K
- Earning Date
- FSBC 07-23-2025
- ARCT 08-04-2025
- Dividend Yield
- FSBC 2.62%
- ARCT N/A
- EPS Growth
- FSBC N/A
- ARCT N/A
- EPS
- FSBC 2.27
- ARCT N/A
- Revenue
- FSBC $124,973,000.00
- ARCT $143,680,000.00
- Revenue This Year
- FSBC $25.86
- ARCT N/A
- Revenue Next Year
- FSBC $15.15
- ARCT $34.79
- P/E Ratio
- FSBC $13.47
- ARCT N/A
- Revenue Growth
- FSBC 11.14
- ARCT 15.38
- 52 Week Low
- FSBC $22.22
- ARCT $8.04
- 52 Week High
- FSBC $35.13
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- FSBC 60.53
- ARCT 51.35
- Support Level
- FSBC $29.76
- ARCT $13.25
- Resistance Level
- FSBC $30.65
- ARCT $15.20
- Average True Range (ATR)
- FSBC 0.76
- ARCT 0.97
- MACD
- FSBC 0.13
- ARCT -0.04
- Stochastic Oscillator
- FSBC 76.88
- ARCT 30.20
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.